Literature DB >> 19626129

Beyond Stressed Self: Evidence for NKG2D Ligand Expression on Healthy Cells.

Robert A Eagle1, Insiya Jafferji, Alexander D Barrow.   

Abstract

The activity of cytotoxic lymphocytes is regulated by the opposing function of stimulatory and inhibitory cell surface receptors. According to the now classical model of Natural Killer (NK) cell activity, the ligands for inhibitory receptors are constitutively expressed on healthy cells but can be lost on infection and on malignant cells. Loss of inhibitory checks will then allow activating signals to predominate, forming the basis of 'missing self recognition'. Natural Killer Group 2D (NKG2D) is an important member of the cohort of activating receptors expressed on Natural Killer (NK) cells and subsets of T cells. Ligands for the NKG2D receptor comprise a diverse array of self-proteins structurally related to MHC class I molecules. Expression of NKG2D ligands can be induced in cells during infection with pathogens, tumourigenesis, and by stimuli such as DNA damage, oxidative stress, and heat shock. Consequently NKG2D has been widely described as participating in 'stressed self' or 'damaged self' recognition. However, a body of evidence has recently emerged to suggest that this intuitive model of NKG2D function may be an oversimplification. NKG2D ligand expression has now widely been reported on cells that could not be described as stressed or damaged. For example activated T cells can express NKG2D ligands, and constitutive expression of NKG2D ligands has been reported on normal myelomonocytic cells, dendritic cells, and epithelial cells of the gut mucosa. In this article we will review the literature suggesting that NKG2D may function to recognise non-stressed cells and discuss the role NKG2D ligands could be playing in apparently healthy cells.

Entities:  

Year:  2009        PMID: 19626129      PMCID: PMC2713595          DOI: 10.2174/157339509787314369

Source DB:  PubMed          Journal:  Curr Immunol Rev        ISSN: 1573-3955


  116 in total

Review 1.  Whatever turns you on: accessory-cell-dependent activation of NK cells by pathogens.

Authors:  Kirsty C Newman; Eleanor M Riley
Journal:  Nat Rev Immunol       Date:  2007-04       Impact factor: 53.106

2.  Promoter region architecture and transcriptional regulation of the genes for the MHC class I-related chain A and B ligands of NKG2D.

Authors:  Gopalakrishnan M Venkataraman; Dominic Suciu; Veronika Groh; Jeremy M Boss; Thomas Spies
Journal:  J Immunol       Date:  2007-01-15       Impact factor: 5.422

3.  Acute upregulation of an NKG2D ligand promotes rapid reorganization of a local immune compartment with pleiotropic effects on carcinogenesis.

Authors:  Jessica Strid; Scott J Roberts; Renata B Filler; Julia M Lewis; Bernice Y Kwong; William Schpero; Daniel H Kaplan; Adrian C Hayday; Michael Girardi
Journal:  Nat Immunol       Date:  2008-01-06       Impact factor: 25.606

4.  NK cell functions restrain T cell responses during viral infections.

Authors:  H C Su; K B Nguyen; T P Salazar-Mather; M C Ruzek; M Y Dalod; C A Biron
Journal:  Eur J Immunol       Date:  2001-10       Impact factor: 5.532

5.  Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK- cell lysis.

Authors:  Cristina Cerboni; Alessandra Zingoni; Marco Cippitelli; Mario Piccoli; Luigi Frati; Angela Santoni
Journal:  Blood       Date:  2007-04-03       Impact factor: 22.113

6.  NKp46 and NKG2D recognition of infected dendritic cells is necessary for NK cell activation in the human response to influenza infection.

Authors:  Monia Draghi; Achal Pashine; Bharati Sanjanwala; Ketevan Gendzekhadze; Claudia Cantoni; David Cosman; Alessandro Moretta; Nicholas M Valiante; Peter Parham
Journal:  J Immunol       Date:  2007-03-01       Impact factor: 5.422

7.  BCR/ABL oncogene directly controls MHC class I chain-related molecule A expression in chronic myelogenous leukemia.

Authors:  Nicolas Boissel; Delphine Rea; Vannary Tieng; Nicolas Dulphy; Manuel Brun; Jean-Michel Cayuela; Philippe Rousselot; Ryad Tamouza; Philippe Le Bouteiller; François-Xavier Mahon; Alexander Steinle; Dominique Charron; Hervé Dombret; Antoine Toubert
Journal:  J Immunol       Date:  2006-04-15       Impact factor: 5.422

8.  NK cells lyse T regulatory cells that expand in response to an intracellular pathogen.

Authors:  Sugata Roy; Peter F Barnes; Ankita Garg; Shiping Wu; David Cosman; Ramakrishna Vankayalapati
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

9.  Macrophage migration inhibitory factor contributes to the immune escape of ovarian cancer by down-regulating NKG2D.

Authors:  Mathias Krockenberger; Yvonne Dombrowski; Claudia Weidler; Monika Ossadnik; Arnd Hönig; Sebastian Häusler; Heike Voigt; Jürgen C Becker; Lin Leng; Alexander Steinle; Michael Weller; Richard Bucala; Johannes Dietl; Jörg Wischhusen
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

10.  Loss of nonclassical MHC molecules MIC-A/B expression during progression of uveal melanoma.

Authors:  C S Vetter; W Lieb; E-B Bröcker; J C Becker
Journal:  Br J Cancer       Date:  2004-10-18       Impact factor: 7.640

View more
  38 in total

Review 1.  Fine tuning a well-oiled machine: Influence of NK1.1 and NKG2D on NKT cell development and function.

Authors:  Sunil K Joshi; Mark L Lang
Journal:  Int Immunopharmacol       Date:  2013-06-22       Impact factor: 4.932

2.  T Cells Engineered With Chimeric Antigen Receptors Targeting NKG2D Ligands Display Lethal Toxicity in Mice.

Authors:  Heather VanSeggelen; Joanne A Hammill; Anna Dvorkin-Gheva; Daniela G M Tantalo; Jacek M Kwiecien; Galina F Denisova; Brian Rabinovich; Yonghong Wan; Jonathan L Bramson
Journal:  Mol Ther       Date:  2015-06-30       Impact factor: 11.454

3.  Targeting multiple types of tumors using NKG2D-coated iron oxide nanoparticles.

Authors:  Ming-Ru Wu; W James Cook; Tong Zhang; Charles L Sentman
Journal:  Nanotechnology       Date:  2014-11-05       Impact factor: 3.874

Review 4.  Tailoring Natural Killer cell immunotherapy to the tumour microenvironment.

Authors:  Alexander David Barrow; Marco Colonna
Journal:  Semin Immunol       Date:  2017-09-19       Impact factor: 11.130

5.  NKG2D ligand expression in Crohn's disease and NKG2D-dependent stimulation of CD8+ T cell migration.

Authors:  Kasper Vadstrup; Elisabeth Douglas Galsgaard; Helle Jensen; Lewis L Lanier; James C Ryan; Shih-Yu Chen; Garry P Nolan; Marianne Kajbæk Vester-Andersen; Julie Steen Pedersen; Jens Gerwien; Teis Jensen; Flemming Bendtsen
Journal:  Exp Mol Pathol       Date:  2017-07-03       Impact factor: 3.362

6.  The nuclear factor-κB pathway down-regulates expression of the NKG2D ligand H60a in vitro: implications for use of nuclear factor-κB inhibitors in cancer therapy.

Authors:  Carlos Peinado; Xi Kang; Chanae Hardamon; Sumit Arora; Stephen Mah; Hui Zhang; Jennifer Ngolab; Jack D Bui
Journal:  Immunology       Date:  2013-06       Impact factor: 7.397

7.  NKG2D Signaling between Human NK Cells Enhances TACE-Mediated TNF-α Release.

Authors:  Neekun Sharma; Camille V Trinidad; Andrew P Trembath; Mary A Markiewicz
Journal:  J Immunol       Date:  2017-09-11       Impact factor: 5.422

8.  Inhibition of MMP activity can restore NKG2D ligand expression in gastric cancer, leading to improved NK cell susceptibility.

Authors:  Kensuke Shiraishi; Kousaku Mimura; Ley-Fang Kua; Vivien Koh; Lim Kee Siang; Shotaro Nakajima; Hideki Fujii; Asim Shabbir; Wei-Peng Yong; Jimmy So; Seiichi Takenoshita; Koji Kono
Journal:  J Gastroenterol       Date:  2016-03-22       Impact factor: 7.527

9.  Characterization of a novel NKG2D and NKp46 double-mutant mouse reveals subtle variations in the NK cell repertoire.

Authors:  Sam Sheppard; Chiara Triulzi; Michele Ardolino; Daniel Serna; Lily Zhang; David H Raulet; Nadia Guerra
Journal:  Blood       Date:  2013-05-06       Impact factor: 22.113

10.  Altered expression of Raet1e, a major histocompatibility complex class 1-like molecule, underlies the atherosclerosis modifier locus Ath11 10b.

Authors:  José M Rodríguez; Susanne Wolfrum; Megan Robblee; Kwan Y Chen; Zachary N Gilbert; Jae-Hoon Choi; Daniel Teupser; Jan L Breslow
Journal:  Circ Res       Date:  2013-08-15       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.